Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Gains from Sales and Divestitures (2018 - 2020)

Historic Gains from Sales and Divestitures for vTv Therapeutics (VTVT) over the last 3 years, with Q4 2020 value amounting to $11667.0.

  • vTv Therapeutics' Gains from Sales and Divestitures changed N/A to $11667.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $11667.0, marking a year-over-year change of. This contributed to the annual value of $11667.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that vTv Therapeutics reported Gains from Sales and Divestitures of $11667.0 as of Q4 2020.
  • Over the past 5 years, vTv Therapeutics' Gains from Sales and Divestitures peaked at $11667.0 during Q2 2018, and registered a low of $11666.0 during Q1 2018.
  • Over the past 3 years, vTv Therapeutics' median Gains from Sales and Divestitures value was $11667.0 (recorded in 2018), while the average stood at $11666.6.
  • In the last 5 years, vTv Therapeutics' Gains from Sales and Divestitures fell by 0.86% in 2019 and then rose by 0.86% in 2020.
  • Over the past 3 years, vTv Therapeutics' Gains from Sales and Divestitures (Quarter) stood at $11667.0 in 2018, then decreased by 0.01% to $11666.0 in 2019, then grew by 0.01% to $11667.0 in 2020.
  • Its Gains from Sales and Divestitures was $11667.0 in Q4 2020, compared to $11667.0 in Q3 2020 and $11667.0 in Q2 2020.